CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations

15Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Pacia, D. M., Brown, B. L., Minssen, T., & Darrow, J. J. (2024). CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations. Journal of Law and the Biosciences, 11(1). https://doi.org/10.1093/jlb/lsad030

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free